We are live on
!
Find out more
Black Diamond Therapeutics
BDTX
BDTX
104 hedge funds and large institutions have $82M invested in Black Diamond Therapeutics in 2026 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
4% more call options, than puts
Call options by funds: $229K | Put options by funds: $221K
0.78% more ownership
Funds ownership: 66.45% → 67.23% (+0.78%)
0% more funds holding
Funds holding: 104 → 104 (0)
11% less capital invested
Capital invested by funds: $92M → $82M (-$9.99M)
12% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 34
Holders
104
Holders Change
–
Holders Change %
0%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
30
Reduced
34
Closed
21
Calls
$229K
Puts
$221K
Net Calls
+$8K
Net Calls Change
-$414K
Top Buyers
Top Sellers
| 1 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$2.54M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$2.11M |
| 3 |
Jane Street
New York
|
-$2.06M |
| 4 |
D.E. Shaw & Co
New York
|
-$694K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$656K |
